Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam
· Delayed Price · Currency is VND 62,900
-100 (-0.16%)
At close: Mar 6, 2026
HNX:DP3 Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,311,496 | 1,135,196 | 1,253,446 | 1,408,246 | 808,400 | 971,800 | Upgrade
|
| Market Cap Growth | 0% | -9.43% | -10.99% | 74.20% | -16.81% | 30.18% | Upgrade
|
| Enterprise Value | 870,240 | 736,739 | 929,277 | 1,160,824 | 640,122 | 859,776 | Upgrade
|
| Last Close Price | 61000.00 | 52800.00 | 55479.03 | 59751.45 | 31646.29 | 36075.15 | Upgrade
|
| PE Ratio | 8.54 | 7.39 | 10.34 | 11.24 | 7.43 | 10.31 | Upgrade
|
| PS Ratio | 2.99 | 2.59 | 3.00 | 3.44 | 1.67 | 2.55 | Upgrade
|
| PB Ratio | 2.16 | 1.87 | 2.42 | 3.01 | 1.94 | 2.65 | Upgrade
|
| P/TBV Ratio | 2.23 | 1.93 | 2.51 | 3.14 | 1.97 | 2.70 | Upgrade
|
| P/FCF Ratio | - | 4.69 | 13.86 | 9.60 | 9.61 | 37.58 | Upgrade
|
| P/OCF Ratio | 5.42 | 4.69 | 13.64 | 9.20 | 8.15 | 36.94 | Upgrade
|
| EV/Sales Ratio | 1.99 | 1.68 | 2.23 | 2.83 | 1.32 | 2.26 | Upgrade
|
| EV/EBITDA Ratio | 4.78 | 4.05 | 6.21 | 7.69 | - | - | Upgrade
|
| EV/EBIT Ratio | 5.10 | 4.32 | 6.80 | 8.48 | 5.01 | 7.67 | Upgrade
|
| EV/FCF Ratio | - | 3.04 | 10.27 | 7.91 | 7.61 | 33.24 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | - | 0.02 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.19 | 0.19 | - | 0.05 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.14 | 0.14 | - | 0.05 | 0.06 | 0.14 | Upgrade
|
| Net Debt / Equity Ratio | -0.73 | -0.73 | -0.66 | -0.64 | -0.48 | -0.43 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.42 | -2.42 | -2.28 | -1.98 | - | - | Upgrade
|
| Net Debt / FCF Ratio | -1.82 | -1.82 | -3.78 | -2.03 | -2.39 | -6.12 | Upgrade
|
| Asset Turnover | 0.64 | 0.64 | 0.71 | 0.76 | 1.02 | 0.86 | Upgrade
|
| Inventory Turnover | 2.99 | 2.99 | 2.94 | 2.10 | 2.17 | 1.90 | Upgrade
|
| Quick Ratio | 3.55 | 3.55 | 4.29 | 3.25 | 2.60 | 2.31 | Upgrade
|
| Current Ratio | 3.96 | 3.96 | 4.88 | 3.79 | 3.43 | 3.22 | Upgrade
|
| Return on Equity (ROE) | 27.26% | 27.26% | 24.55% | 28.28% | 27.77% | 26.46% | Upgrade
|
| Return on Assets (ROA) | 15.62% | 15.62% | 14.50% | 15.87% | 16.76% | 15.81% | Upgrade
|
| Return on Invested Capital (ROIC) | 90.02% | 71.80% | 62.83% | 56.58% | 48.04% | 44.85% | Upgrade
|
| Return on Capital Employed (ROCE) | 28.00% | 28.00% | 26.30% | 29.20% | 30.60% | 30.60% | Upgrade
|
| Earnings Yield | 11.71% | 13.53% | 9.67% | 8.89% | 13.46% | 9.70% | Upgrade
|
| FCF Yield | - | 21.32% | 7.22% | 10.42% | 10.41% | 2.66% | Upgrade
|
| Dividend Yield | 6.44% | - | - | 5.02% | - | 6.65% | Upgrade
|
| Payout Ratio | 40.50% | 40.50% | 53.22% | 54.84% | 45.84% | 70.55% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | 5.00% | -5.27% | 0.00% | Upgrade
|
| Total Shareholder Return | 6.44% | - | - | 10.02% | -5.27% | 6.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.